Renal Endocrine Flashcards

(32 cards)

1
Q

is the principal circulating form of vitamin D.

A

25-hydroxycholecalciferol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The enzyme is responsible for the hydroxylation step necessary to produce 1,25-(OH)2-cholecalciferol from 25-hydroxycholecalciferol.

A

1-alpha-hydroxylase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Vitamin D3, which can be acquired from milk in the diet, is known as .

A

CHOLECALCIFEROL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When it comes to new bone, the role of vitamin D is to promote .

A

Mineralization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The major actions of 1,25-dihydroxycholecalciferol are on the , kidneys and bones.

A

INTESTINE
KIDNEY
BONES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

25-hydroxycholecalciferol is bound to a/an in plasma.

A

alpha-globulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

25-hydroxycholecalciferol is physiologically (active/inactive) .

A

INACTIVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

On the intestine, 1,25-dihydroxycholecalciferol increases calcium and phosphate absorption, by inducing the synthesis of a vitamin D-dependent calcium-binding protein known as .

A

Calbindin D-28k

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The second major regulator of calcium and phosphate metabolism (after parathyroid hormone) is .

A

Vitamin D

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The enzyme 1-alpha-hydroxylase is (stimulated/inhibited) by low concentrations of calcium and phosphate.

A

STIMULATED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In the kidneys 25-hydroxycholecalciferol can be hydroxylated at the carbon-1 position to the active form known as .

A

1,25-(OH)2D3 (calcitriol).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

1,25-dihydroxycholecalciferol action on the kidney is to stimulate calcium (and/but not) phosphate absorption.

A

AND

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Vitamin D is a (polypeptide/steroid) hormone

A

Steroid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cholecalciferol is produced in the skin from in the presence of ultraviolet light, and also acquired from the diet.

A

7-dehydrocholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The action of vitamin D is to (increase/decrease) both calcium and phosphate concentrations in plasma

A

INCREASE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The hydroxylation of cholecalciferol is regulated by (positive/negative) feedback mechanisms.

17
Q

Cholecalciferol is hydroxylated in the liver to form

A

25-hydroxycholecalciferol.

18
Q

Calbindin D-28K is the calcium-binding protein induced by in the intestine.

19
Q

Decreased plasma calcium and _____ concentration stimulate the enzyme 1-alpha-hydroxylase.

20
Q

In bone, 1,25-dihydroxycholecalciferol acts together with to stimulate osteoclast activity and bone resorption.

21
Q

The enzyme 1-alpha-hydroxylase is stimulated by (hormone) .

22
Q

Cholecalciferol is physiologically (active/inactive)

23
Q

Vitamin D increases the plasma concentration of calcium (and/but not of) phosphate.

24
Q

Low concentrations of and phosphate stimulate the enzyme 1-alpha-hydroxylase.

25
Vitamin D2, which can be acquired from plant foods in the diet, is known as .
Ergocalciferol
26
When hypoxia occurs there is increased production of , which is the first step in erythropoietin synthesis.
Hypoxia-Inducible factor 1 alpha
27
Decreased function of renal tissue results in decreased erythropoietin synthesis, which can cause .
ANEMIA
28
Hypoxia-inducible factor 1-alpha acts on fibroblasts in the renal cortex and medulla to cause synthesis of for erythropoietin.
mRNA
29
When the oxygen content of arterial blood is (increased/decreased) , the kidney is signalled to produce more erythropoietin.
DECREASED
30
is a treatment option for anemia of chronic renal failure.
Recombinant EPO
31
The are the ideal site for erythropoietin synthesis because they can determine whether the decreased oxygen delivery is due to decreased blood flow or decreased oxygen content of arterial blood.
KIDNEYS
32
Erythropoietin acts to induce differentiation of .
PROERTHYTOBLASTS